M&A

Kimberly-Clark Finishes Its $48.7 Billion Bet That Tylenol Belongs Next to Kleenex

Kimberly-Clark closed its $48.7 billion acquisition of Kenvue, merging Huggies and Kleenex with Tylenol, Neutrogena, and Listerine into a single consumer health giant with ten billion-dollar brands.

By , Founder & Editor•Nov 4, 2026•5 min read
Kimberly-Clark Finishes Its $48.7 Billion Bet That Tylenol Belongs Next to Kleenex
M&A
Kimberly-Clark Finishes Its $48.7 Billion Bet That Tylenol Belongs Next to Kleenex

Kimberly-Clark officially closed its purchase of Kenvue on November 2, folding the company that makes Tylenol, Neutrogena, and Listerine into the one that makes Huggies, Kleenex, and Scott. Kenvue stock stopped trading at the opening bell that morning; every share converted into $3.50 in cash plus 0.14625 shares of Kimberly-Clark stock, a structure built around an original enterprise value of about $48.7 billion.

The combined company now holds ten billion-dollar brands, including Huggies, Listerine, Cottonelle, Neutrogena, Depend, Tylenol, Kleenex, Johnson's Baby, Kotex, and Scott, organized into four regional segments worth roughly $31 billion in annual sales. CEO Mike Hsu called the merged company "equipped to combine deep consumer insight, groundbreaking science and innovation," and said the priority now is to "move with speed and purpose to unlock the full potential of this combination." Kimberly-Clark is targeting about $2.1 billion in run-rate synergies, split between roughly $1.9 billion in cost savings over three years and $500 million in incremental revenue, though the European Commission only signed off after Kimberly-Clark agreed to divest the Kotex, Camelia, and Record brands in the European Economic Area to resolve an overlap with Kenvue's tampon business.

Pairing a diaper-and-toilet-paper company with a medicine cabinet was always a strange marriage on paper, and investors treated it that way for most of the year. But a combined shelf that runs from Huggies to Tylenol to Listerine gives Kimberly-Clark something most consumer giants would kill for: a single cart that follows a household from the nursery through the medicine cabinet, with the retailer relationships and shelf space to back it up. Whether that translates into actual cross-selling, or just a bigger balance sheet carrying more brands that quietly compete with each other for the same shopper's attention, is the question Kimberly-Clark's next few quarters will have to answer.

Source: Kimberly-Clark

, Founder & Editor, BRNDWIRE. More from Kyle →

More stories